Inflammation genes and childhood trauma in people with hidradenitis suppurativa
Compares inflammation signals in people with hidradenitis suppurativa and controls, plus childhood trauma effects.
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Registry title
- Regulation of Inflammatory Genes in Hidradenitis Suppurativa
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 11 Oct 2022
- Expected to end
- 31 Aug 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Mental health
- Record updated
- 21 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with hidradenitis suppurativa (HS), a long-lasting skin disease with painful lumps, and for control people without inflammatory skin disease. It studies inflammation genes in the blood and skin. An optional extra study looks at how childhood trauma affects HS.
- Age
- 18 Years to 89 Years
- Sex
- All sexes
- Disease stage
- People in the HS group must have a diagnosis of hidradenitis suppurativa. People in the control group must not have an inflammatory skin disease.
Main reasons for not taking part
- Being pregnant
- Control group: having HS, psoriasis, rosacea, atopic dermatitis or another inflammatory skin disease
- Mild or general skin issues such as moles or other cosmetic problems
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Diagnosed with hidradenitis suppurativa
- Not Pregnant
Who cannot take part
- Patients with hidradenitis suppurativa, psoriasis, roasacea, atopic dermatitis and other inflammatory skin disease
- Mild/general dermatological issues like moles, other cosmetic issues
- Pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- Whitaker ClinicBirmingham, United StatesContact: Nabiha YusufTaking people
About the trial
What the trial wants to find out
The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal
The 2 groups in the trial
- Control
Participants without inflammatory skin disease
Treatment: Mental health
- Patients with HS
Treatment: Mental health
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Regulation of Inflammatory Genes in Hidradenitis Suppurativa
- Plain-language title
- Inflammation genes and childhood trauma in people with hidradenitis suppurativaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05507125, who can take part
- Record updated
- 21 September 2026